Spontaneous bacterial peritonitis pathophysiology

Peritonitis main page
Spontaneous bacterial peritonitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Spontaneous bacterial peritonitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History & Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Spontaneous bacterial peritonitis pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Spontaneous bacterial peritonitis pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Spontaneous bacterial peritonitis pathophysiology
CDC on Spontaneous bacterial peritonitis pathophysiology
Spontaneous bacterial peritonitis pathophysiology in the news
Blogs on Spontaneous bacterial peritonitis pathophysiology
Directions to Hospitals Treating Spontaneous bacterial peritonitis
Risk calculators and risk factors for Spontaneous bacterial peritonitis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shivani Chaparala M.B.B.S [2]

Overview

SBP is a result of culmination of the inability of the gut to contain bacteria and failure of the immune system to eradicate the organisms once they have escaped into the blood stream. Factors related to cirrhosis and ascites predispose to the development of SBP, they include : altered microbial flora, hypo-motility of the intestine, intestinal bacterial overgrowth, increased Intestinal mucosal permeability, bacterial translocation to lymph nodes. Presence of ascites appears to be an important risk factor for the development of bacterial translocation. In healthy individuals, bacteria that colonize lymph nodes are killed by local immune defenses. However, in cirrhosis and aquired state of immunodeficiency, the following changes in the immune defences can be present : malfunctioning of the reticulo-endothelial and neutrophilic system, reduced cellular and humoral bactericidal function which favor the spread of bacteria to the blood stream. Bacteremia in healthy individuals results in rapid coating by IgG and/or Complement components and removal of the bacteria by neutrophils in the circulation. In cirrhosis, decreased serum levels of complement components (C3, C4), impaired chemotaxis, poor function and phagocytic activity of neutrophils, decreased function of Fc-gamma-receptors in macrophages, hepatic Reticuloendothelial system (RES) dysfunction, with reduced Kupffer cells, intrahepatic and extra porto systemic shunts prevent circulating bacteria from encountering the kupper cells and impaired neutrophilic function result in decreased immune response and clearance of the bacteria. The consequence of these abnormalities is prolongation of bacteremia and eventual seeding of other sites, including the ascitic fluid. The presence of bacteria in ascitic fluid does not consititute to peritonitis without signs and symptoms. Ascitic fluid due to cirrhosis can mount a humoral self-defense with the help of complement system. Patients with adequate activity of this vital bactericidal system do not develop ascitic fluid infections. Patients with ascitic fluid C3 less than1g/dl and a protein level less than 1g/dl have an increased predisposition to SBP. Low complement levels result in inadequate killing of the bacteria lead to the development of infection. Finally, Bacteremia/ Endotoxemia leads to activation of cytokine cascade and release effector molecules such as NO and TNF casuing vasodilation and reduced renal perfusion.

Pathophysiology

Patients with decompensated cirrhosis leading to portal Hypertension                   Intestinal hypo-motility and local pro-inflammatory phenomenon                   Bacterial overgrowth: Increased intestinal permeability and decreased local and systemic immune system in cirrhosis and its relation to bacterial infections and prognosis.                   Routes of entry of pathogens into the ascitic fluid Escape of enteric bacteria to systemic circulation through: ❑ Bacterial translocation • Luminal bacteria within colonize mesenteric lymph nodes. • Organisms from the mesenteric lymph nodes → Systemic circulation through thoracic duct lymph → percolates through the liver and weep across Glisson's capsule → Ascitic fluid. • Transient bacteremia → Prolonged bacteremia ( due to ↓ Reticulo endothelial system activity ) → Ascites Colonization ( due to ↓ ascitic fluid bactericidal activity ) → Spontaneous bacterial peritonitis ) ❑ Portal Vein • Porto-systemic shunt • ↓RES function in the liver ❑ Lymphatic rupture • Contaminated lymph carried by lymphatics • Ruptured Lymphatics due to high flow and high pressure associated with portal hypertension ( BACTERASCITES ) ❑ Other source of organisms • IV catheters, skin, urinary, and respiratory tract                   Endotoxemia and Cytokine response ❑ Endotoxemia → release of pro-inflammatory cytokines produced by macrophages and other host cells in response to bacteria in the serum and peritoneal exudate • Tumor necrosis factor-α (TNF-α) • Interleukin (IL)-1,6 • Interferon-γ (IFN-γ) • Soluble adhesion molecules ❑ Systemic and Abdominal manifestations of peritonitis mediated by cytokines • The effector molecules (Nitric oxide) and cytokines,Tumour necrosis factor (TNF) that help kill the bacteria have undesired side effects as they cause vasodilation and renal failure that accompany SBP. • Studies have shown that the presence of whole bacteria or DNA, in serum and ascitic fluid leads to stimulation of immune defences, effector molecules, and cytokines which in turn impact on hemodynamics, renal function and survival.                   Host response ❑ Local response Outpouring of fluid into the peritoneal cavity at sites of irritation with: • High protein content (>3 g/dL) • Many cells, primarily polymorphonuclear leukocytes, that phagocytose and kill organisms • Formation of Fibrinous exudate on the inflamed peritoneal surfaces → Adhesion formation between adjacent bowel, mesentery, and omentum • Localization of the inflammatory process is aided further by inhibition of motility in the involved intestinal loops • The extent and rate of intraperitoneal spread of contamination depend on the volume and nature of the exudate and on the effectiveness of the localizing processes • If peritoneal defenses aided by the appropriate supportive measures control the inflammatory process, the disease may resolve spontaneously (Sterile ascites) → Consumption of humoral bactericidal factors due to frequent colonization → Increased susceptibility to SBP • If the ascitic fluid bactericidal activity is poor-moderate → Culture negative neutrocytic ascites (CNNA) or SBP → delay / inappropriate treatment → death due to sepsis and multi organ failure. • Second possible outcome is a confined abscess • A third possible outcome results when the peritoneal and systemic defense mechanisms are unable to localize the inflammation, which progresses to spreading diffuse peritonitis due to increased virulence of bacteria, greater extent and duration of contamination, and impaired host defenses. ❑ Systemic response Gastrointestinal • Paralysis of the bowel due to local inflammation • Progressive accumulation of fluid and electrolytes in the lumen of the adynamic bowel → distention of the bowel → inhibition of the capillary inflow and secretions • GI bleeding because of excessive inflammation and tissue damage → ↑ vasodilatation and ↓organ perfusion Cardiovascular • Shift of fluid into the peritoneal cavity and bowel lumen → ↓ Effective circulating blood volume → ↑ Hematocrit and • ↑Fluid and electrolyte loss by coexistent fever, vomiting, diarrhea → decreased venous return to the right side of the heart → decrease in cardiac output → hypotension → activation of the sympathetic nervous system and manifestations such as sweating, tachycardia, and cutaneous vasoconstriction (i.e., cold, moist skin and mottled, cyanotic extremities). • If the blood volume replaced is sufficient enough as so to increase the cardiac output 2-3 times normal ( to satisfy the increased metabolic needs of the body in the presence of infection) a halt in the progression of the disease is seen. • Failure to sustain increased cardiac output results in progressive lactic acidosis, oliguria, hypotension, and ultimately death if the infection cannot be controlled. Respiratory • Intra-peritoneal inflammation → high and fixed diaphragm → pain on respiration → basilar atelectasis with intrapulmonary shunting of blood • Decompensation of respiratory function due to delay in the intervention → hypoxemia + hypo-capnia (respiratory alkalosis) followed by hypercapnia (respiratory acidosis) • Pulmonary edema results because of increased pulmonary capillary leakage as a consequence of hypo-albuminemia or direct effects of bacterial toxins (adult respiratory distress syndrome) → progressive hypoxemia with decreasing pulmonary compliance which needs a ventilator assistance with increasingly higher concentrations of inspired oxygen and positive end-expiratory pressure. Renal • SBP → Splanchnic arterial vasodilation and systemic vascular resistance → ↓ Effective arterial blood volume → stimulation of systemic vasoconstrictors (RAAS, Sympathetic Nervous System, Arginine vasopressin) → renal vasoconstriction • Advanced cirrhosis → ↓ production of local vasodilators and ↑ production of local vasoconstrictors → Hepatorenal syndrome and death. • ↓ Organ perfusion → Ischemic and Toxic Acute Tubular Necrosis → Acute Renal Failure → Death in (30-40%) of patients. Metabolic • Infection → ↓body stores of Glycogen → catabolism of protein (muscle) and →extreme wasting and rapid weight loss of severely infected patients • Infection → ↓Body heat production → exhaustion and death Central nervous system • Hepatic Encephalopathy may occur due to inflammation, Oxidative stress and Intestinal ammonia production on crossing the blood-brain barrier → altered mentation. Hematological • Sepsis → DIC

Diagramatic representation of pathological bacterial translocation and the associated host response

Bacterial Translocation

It is defined as the translocation of either bacteria or bacterial products such as lipopolysaccharides (LPS), bacterial DNA, peptidoglycans, muramyl-dipeptides from gut into mesenteric lymph nodes.

Physiological: It is the normal bacterial translocation in healthy individuals due to lack of pro-inflammatory responses against commensal bacteria. Physiological translocation is crucial for the development of host immunity response.

Pathological: It is developed due to abnormal increase in physiological translocation in both rate and degree by breaking the normal immunological barriers.

Barriers that limit pathological transmission:

1. Interstinal lumen and it's secretory components such as inner and outer mucus layer, antimicrobial peptides: This is the primary barrier that limit direct contact between the intestinal bacteria and the epithelial cell surface
2. Epithelial barrier with the gut-associated lymphatic tissue (GALT) and autonomic nervous system: This is a mechanical barrier with local immunological response elements (e.g., TNF and other pro-inflammatory cytokines) that rapidly detects and kill the pathogen that manage to penetrate.
3. Systemic immune system: This includes hematogenous (portal venous) and lymphatic (ductus thoracicus) route of delivery that acts as a third immune barrier to prevent or minimize the pathogen to disseminate systemically from local immune system such as lymph nodes.

Mechanism of pathological bacterial translocation

Breaking these immune barriers can progress physiological bacterial translocation into pathological bacterial translocation.

Bacterial Translocation	Adapted from Journal of hepatology:Pathological bacterial translocation in liver cirrhosis.
	I. Immune response by gut associated lymphoid tissue	A. Innate immunity	Innate immunity is the first line of defense mechanism against invading pathogen that detects common bacterial motifs such as microbial-associated molecular patterns (MAMPs) through germline-coded pattern-recognition receptors (PRR) on intestinal cells. Mechanism of breaking of innate immunity Dendritic cells below the epithelial layer allows pathogen via dendritic processes with out affecting tight junction function. Disruption of epithelial barrier by antigenic properties of the pathogen with the underlying epithelial layer and compromises its epithelial integrity. Access provided by M- cells overlying payers patches with in the villous epithelium through antigen presenting cells.
		B. Adaptive immunity	Bacterial translocation through epithelial cells ⬇ Release of chemokines form epithelial cells. ⬇ Recruitment of dendritic cells towards mucosa ⬇ Dendritic cells induces adaptive immunity through mucosal B and T lymphocytes ⬇ a. Bacterial antigen present to Matured T lymphocytes, followed by activation B-lymphocytes through T helper cells b. Antigen presenting cells present microbial antigen to matured B lymphocytes, eventually B-cell releases IgA mucosal immunoglobulins against pathogen and it's product Mechanism of breaking adaptive immunity: Due to the underlying immunocompromised states such as cirrhosis, there is a depletion of both T and B cells and hypogamaglobilinemia, results in weak development of adaptive immunity with insufficient bacterial killing that leads to lethal dissemination of commensal bacteria.
	II. Mesenteric lymph nodes (MLN)		In a healthy gut, dendritic cells transport pathological bacteria to mesenteric lymph nodes which induces local immune response and are killed without inducing systemic immunity. In immunocompromised state, lack of local immune response by MLN is reduced, eventually permits the translocation of intestinal bacteria systemically, which eventually may lead to sepsis and death. Mechanism involving in spreading bacteria beyond MLN: Deficient innate and adaptive immunity Impaired chemotactic, opsonic, phagocytic activity of macropharges Impaired RES activity
	III. Systemic immune response		Translocation beyond MLN through hematogenous or lymphatic path is specific and depends on the microbial-specific systemic immune response. Lymphatic and portalvenous route in parallel are disrupt in liver cirrhosis which results in dissemination of bacterial pathogen.

• Contrary to earlier theories, transmucosal migration of bacteria from the gut to the ascitic fluid is no longer considered to play a major role in the etiology of SBP.

• With respect to compromised host defenses, patients with severe acute or chronic liver disease are often deficient in complement and may also have malfunctioning of the neutrophilic and reticuloendothelial systems.

• As for the significance of ascitic fluid proteins, it was demonstrated that cirrhotic patients with ascitic protein concentrations below 1 g/dL were 10 times more likely to develop SBP than individuals with higher concentrations. It is thought that the antibacterial, or opsonic, activity of ascitic fluid is closely correlated with the protein concentration. Additional studies have confirmed the validity of the ascitic fluid protein concentration as the best predictor of the first episode of SBP.